X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (27) 27
humans (20) 20
glioblastoma (16) 16
female (15) 15
male (15) 15
middle aged (15) 15
oncology (15) 15
adult (12) 12
aged (12) 12
temozolomide (12) 12
care and treatment (10) 10
chemotherapy (10) 10
glioblastoma multiforme (10) 10
patients (10) 10
survival (10) 10
bevacizumab (9) 9
cancer (9) 9
brain cancer (8) 8
magnetic resonance imaging (8) 8
glioblastoma - drug therapy (7) 7
glioblastoma - pathology (7) 7
retrospective studies (7) 7
tumors (7) 7
analysis (6) 6
animals (6) 6
brain neoplasms - diagnostic imaging (6) 6
brain neoplasms - pathology (6) 6
cell biology (6) 6
glioma (6) 6
medicine & public health (6) 6
mice (6) 6
pseudoprogression (6) 6
radiotherapy (6) 6
brain neoplasms - drug therapy (5) 5
clinical neurology (5) 5
disease progression (5) 5
hematology (5) 5
radiation therapy (5) 5
research (5) 5
treatment outcome (5) 5
tyrosine (5) 5
abstracts (4) 4
brain tumors (4) 4
brain-tumors (4) 4
cancer research (4) 4
development and progression (4) 4
disease-free survival (4) 4
glioblastoma - diagnostic imaging (4) 4
gliomas (4) 4
lomustine (4) 4
mri (4) 4
neurology (4) 4
progression (4) 4
radiopharmaceuticals (4) 4
recurrent glioblastoma (4) 4
response assessment (4) 4
rodents (4) 4
tyrosine - analogs & derivatives (4) 4
adolescent (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
brain neoplasms - mortality (3) 3
camptothecin - analogs & derivatives (3) 3
cancer therapies (3) 3
cellular biology (3) 3
clinical trials (3) 3
complications and side effects (3) 3
diagnosis (3) 3
differentiation (3) 3
dna methylation (3) 3
gene expression (3) 3
glioblastoma - genetics (3) 3
heart enlargement (3) 3
heterogeneity (3) 3
high-grade glioma (3) 3
in-vitro (3) 3
inflammation (3) 3
internal medicine (3) 3
irinotecan (3) 3
malignant gliomas (3) 3
medical diagnosis (3) 3
medical imaging (3) 3
medical research (3) 3
medicine (3) 3
medicine, experimental (3) 3
motivation (3) 3
neoplasm recurrence, local - drug therapy (3) 3
newly-diagnosed glioblastoma (3) 3
nuclear magnetic resonance--nmr (3) 3
phase-ii trial (3) 3
phase-iii (3) 3
plus irinotecan (3) 3
positron-emission tomography (3) 3
prognosis (3) 3
quality of life (3) 3
radiology, nuclear medicine & medical imaging (3) 3
sepsis (3) 3
studies (3) 3
surgery (3) 3
tissue (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuro-Oncology, ISSN 1522-8517, 11/2018, Volume 20, Issue suppl_6, pp. vi138 - vi139
Abstract INTRODUCTION Tumor Treating Fields (TTFields) is approved for the treatment of newly diagnosed and recurrent glioblastoma. The efficacy and safety of... 
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2018, Volume 20, Issue suppl_6, pp. vi143 - vi143
Abstract INTRODUCTION Tumor Treating Fields (TTFields) are an established modality for glioblastoma (GBM) treatment administered through the portable Optune... 
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 2015, Volume 42, Issue 5, pp. 685 - 695
Journal Article
The Lancet, ISSN 0140-6736, 02/2019, Volume 393, Issue 10172, pp. 678 - 688
Journal Article
Journal Article
Journal Article
Experimental Cell Research, ISSN 0014-4827, 10/2016, Volume 348, Issue 1, pp. 95 - 105
Pressure overload induces cardiac remodeling involving both the contractile machinery and intercalated disks (IDs). Filamin C (FlnC) and Xin actin-binding... 
XIRP2 | Xin actin-binding repeat-containing proteins | Connexin43 | Xirp1 | Cross-striated muscle cells | Filamin C | ECCENTRIC CONTRACTIONS | ARRHYTHMIC SUSCEPTIBILITY | XIN-REPEATS | CONDUCTION DEFECTS | HUMAN SKELETAL-MUSCLE | TRANSITIONAL JUNCTION | CELL BIOLOGY | IMMUNOELECTRON MICROSCOPY | GAP-JUNCTIONS | ONCOLOGY | HEART DEVELOPMENT | CONNEXIN-43 EXPRESSION | Constriction, Pathologic | Cardiomegaly - pathology | Arrhythmias, Cardiac - diagnostic imaging | DNA-Binding Proteins - deficiency | Sarcomeres - pathology | Arrhythmias, Cardiac - pathology | DNA-Binding Proteins - metabolism | Hypertrophy, Left Ventricular - pathology | Myocardium - metabolism | Nuclear Proteins - deficiency | Electrocardiography | Tachycardia - complications | Female | Tachycardia - pathology | Connexin 43 - metabolism | Cardiomegaly - diagnostic imaging | Myocardium - pathology | Nuclear Proteins - metabolism | Cardiomegaly - complications | Aorta - pathology | Tachycardia - diagnostic imaging | Filamins - metabolism | Phenotype | Animals | Hypertrophy, Left Ventricular - complications | Arrhythmias, Cardiac - complications | Mice | Hypertrophy, Left Ventricular - diagnostic imaging | Heart | Tachycardia | Heart enlargement | Physiological aspects | Muscles | Muscle proteins | Cells | Protein binding | Cellular biology | Genotype & phenotype
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 04/2019, Volume 145, Issue 4, pp. 1037 - 1042
PurposeAntiangiogenic treatment approaches have failed to improve outcome in randomized trials of high-grade astrocytoma. One key mechanism of resistance to... 
Regorafenib | High-grade glioma | Astrocytoma | Glioblastoma | TRIAL | ANGIOGENESIS | ONCOLOGY | BEVACIZUMAB | PATTERNS | Complications and side effects | Care and treatment | Relapse | Gliomas | Diseases
Journal Article
Journal Article
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2017, Volume 19, Issue suppl_6, pp. vi208 - vi208
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0142921
Transverse aortic constriction provokes a pro-inflammatory reaction and results in cardiac hypertrophy. Endogenous ligands contribute to cardiac hypertrophy... 
ISCHEMIA-REPERFUSION INJURY | HEART | HYPERTROPHY | IMMUNITY | ACTIVATION | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | IN-VIVO | GENE-EXPRESSION | MONOCYTES | RECEPTOR 4-DEFICIENT MICE | Inflammation - chemically induced | Inflammation - pathology | Lipopolysaccharides - toxicity | Toll-Like Receptor 2 - genetics | Signal Transduction | Humans | Lipopolysaccharides - administration & dosage | Toll-Like Receptor 4 - genetics | Mice, Transgenic | Aorta - metabolism | Toll-Like Receptor 2 - biosynthesis | Toll-Like Receptor 4 - metabolism | Aorta - pathology | Animals | Hypertrophy, Left Ventricular - genetics | Inflammation - genetics | Ligands | Mice | Hypertrophy, Left Ventricular - physiopathology | Teichoic Acids - administration & dosage | Complications and side effects | Development and progression | Genetic aspects | Inflammation | Research | Heart enlargement | Heart | Intensive care | Virulence | Lipoteichoic acid | Inflammatory response | Mitochondrial DNA | Proteins | Receptors | Rodents | Surgery | Toll-like receptors | Bacteria | Aorta | Physiology | Heart diseases | Deoxyribonucleic acid--DNA | CpG islands | Immune system | Stresses | Ventilators | Desensitization | Cytokines | Preservation | Pattern recognition | TLR4 protein | Gene expression | Pressure | Orthodontics | TLR9 protein | Stress | Medicine | Signaling | TLR2 protein | Coronary vessels | Sepsis | Anesthesiology | Ventricle | Hemodynamics | Laboratory animals | Hypertrophy | Deoxyribonucleic acid | DNA
Journal Article